Tech Company Financing Transactions

STAT-Diagnostica Funding Round

STAT-Diagnostica, based in Barcelona, scored funding from Boehringer Ingelheim Venture Fund, Caixa Capital and Gilde Healthcare Partners.

Transaction Overview

Company Name
Announced On
10/6/2016
Transaction Type
Venture Equity
Amount
Unknown
Round
Series C
Proceeds Purpose
The additional proceeds will be used to support the 2017 European launch of its DiagCORE Near Patient Testing system.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Baldiri Reixac 4
Barcelona, 08028
Spain
Email Address
Overview
The DiagCORE platform is designed to meet the requirements of decentralized testing environments without compromising assay quality and performance. Our systems deliver true walk-away solutions in single-test consumables offering end-to-end sample to results with the shortest turnaround times.
Profile
STAT-Diagnostica LinkedIn Company Profile
Social Media
STAT-Diagnostica Company Twitter Account
Company News
STAT-Diagnostica News
Facebook
STAT-Diagnostica on Facebook
YouTube
STAT-Diagnostica on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jordi Carrera
  Jordi Carrera LinkedIn Profile  Jordi Carrera Twitter Account  Jordi Carrera News  Jordi Carrera on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/6/2016: MediaShift venture capital transaction
Next: 10/6/2016: Clearpath Robotics venture capital transaction

 

Share this article

 


Where The Data Comes From

We document every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary